Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

China flag China · Delayed Price · Currency is CNY
71.23
+0.55 (0.78%)
Apr 29, 2026, 12:45 PM CST
41.71%
Market Cap 17.42B
Revenue (ttm) 2.62B
Net Income (ttm) 756.37M
Shares Out 246.43M
EPS (ttm) 3.08
PE Ratio 22.94
Forward PE n/a
Dividend 1.70 (2.41%)
Ex-Dividend Date n/a
Volume 3,103,990
Average Volume 5,327,129
Open 68.21
Previous Close 70.68
Day's Range 68.21 - 71.65
52-Week Range 49.70 - 85.65
Beta 0.49
RSI 56.30
Earnings Date Apr 22, 2026

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China. The company offers myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory and anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, dry eye treatment medicin... [Read more]

Sector Healthcare
Founded 1977
Employees 2,396
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300573
Full Company Profile

Financial Performance

In 2025, SHE:300573's revenue was 2.47 billion, an increase of 27.24% compared to the previous year's 1.94 billion. Earnings were 695.86 million, an increase of 105.84%.

Financial Statements

News

There is no news available yet.